Silence Therapeutics Plc - American Depository ShareSilence Therapeutics Plc - American Depository ShareSilence Therapeutics Plc - American Depository Share

Silence Therapeutics Plc - American Depository Share

No trades
See on Supercharts

SLN fundamentals

Silence Therapeutics Plc - American Depository Share financial statements, including revenue, expenses, profit, and loss

The total revenue of SLN for the last quarter is 1.48 M USD, and it's 96.76% higher compared to the previous quarter. The net income of Q3 24 is -35.12 M USD.

Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth